BTS opens Singapore consulting office

By Gareth Macdonald

- Last updated on GMT

Related tags: Southeast asia, Singapore

Bayer Technology Services (BTS) has set up a new Singapore office to provide the regions’ drug and chemicals producers with engineering consultation services and micro reaction technology.

Singapore’s manufacturing sector has been growing rapidly with, in terms of the drug industry, Novartis, Roche and Pfizer being just some of the most high profile firms to have invested there in recent years.

These trends were a key motivation for BTS’ new office according to company spokesman Arnold Rajathurai who told in-PharmaTechnologist the firm had followed “potential customers towards this region​.”

Dr Rajathurai explained that: “BTS is starting its South East Asia office … to have a closer look into the growing market in this area especially in [pharmaceutical and chemical manufacturing​.”

He went on to say that the new regional base will provide manufacturers with “engineering and other consulting services like energy efficiency checks and environmental technologies​.”

BTS, which is a subsidiary of German drugmaker Bayer, already has an extensive network of engineering consulting offices, spanning Europe, South America, the US and the Middle East.

In Asia, BTS’ regional headquarters is in Shanghai, China that will managed operations at both the new Singapore office and the unit in Mumbai India that the firm recently set up.

Lonza micro reactors

The other major part of the Singapore office’s core business, according to Rajathurai, will be the provision of specialist microreaction development and production technology to drug and chemicals firms.

Last month BTS’ Ehrfeld Mikrotechnik subsidiary signed andeal with Lonza under which it will act as exclusive worldwide manufacturer and distributor of the Swiss firms’ Development Mircoreactor and Advanced Production Microreactor platforms.

The technologies, which were recently awarded the Sandmeyer prize for industrial chemistry and the Profile in Sustainability award at Informex, have numerous applications in drug production, particularly in the biotechnology field.

Related news

Related products

show more

Shifting the Biomanufacturing Paradigm

Shifting the Biomanufacturing Paradigm

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Technical / White Paper

Adoption of next generation processing and technologies can enable improvements in productivity by streamlining workflows, reducing the manufacturing plant...

Bio4C™ ProcessPad Software Datasheet

Bio4C™ ProcessPad Software Datasheet

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Data Sheet

Biopharmaceutical processes are complex and highly variable in nature. This can result in inconsistent and sometimes unpredictable process outcomes. To...

Follow us


View more